'/%3E%3C/svg%3E){kind=small}
Dr. Mor Miodovnik
Dermatologist and medical oncologist, Head of the Melanoma and Skin Tumors Service at Tel Aviv Medical Center
We respond within 30 minutes
About the Doctor
Dr. Mor Miodovnik is a dermatologist and medical oncologist whose clinical work focuses on melanoma and other skin malignancies. She combines dermatologic expertise with oncology care to evaluate suspicious skin lesions and manage confirmed skin cancers.
Since 2021, she has headed the Melanoma and Skin Tumors Service at Tel Aviv Medical Center. She also works as a medical oncologist in the Skin Tumors Clinic and as a senior dermatologist in the Melanoma Surveillance Clinic.
A significant part of her practice involves early detection of melanoma and monitoring people at increased risk of skin cancer. She also manages rare skin tumors and advanced melanoma, tailoring treatment to the characteristics of the disease and the needs of each patient.
Her clinical approach includes dermoscopy, assessment of pigmented lesions, clinical risk assessment and multidisciplinary care. She follows patients with both early-stage and advanced disease and coordinates systemic treatment when needed.
Dr. Miodovnik studied in the MD-PhD track at the Sackler Faculty of Medicine, Tel Aviv University. Her training includes a dermatology residency at Tel Aviv Medical Center and a research fellowship at University Hospital Schleswig-Holstein in Lübeck, Germany, focusing on immunogenetics and the skin microbiome.
She has contributed to scientific research in melanoma and skin cancer and has participated in international medical conferences. Her research interests include melanoma biology, personalized treatment strategies and emerging therapies in skin oncology.
Scientific publications are available on PubMed.
Areas of expertise
- Dermatology
- Medical oncology
- Melanoma
- Advanced melanoma
- Skin malignancies
- Rare skin tumors
- Assessment of suspicious skin lesions
- Pigmented lesion assessment
- Dermoscopic evaluation
- Early detection of skin cancer
- Skin cancer prevention
- Monitoring of patients at increased risk of skin cancer
- Systemic treatment of skin malignancies
- Multidisciplinary skin cancer care
Professional Experience
- Since 2021 Head of the Melanoma and Skin Tumors Service Tel Aviv Medical Center, Israel
- Medical Oncologist, Skin Tumors Clinic Tel Aviv Medical Center, Israel
- Senior Dermatology Physician, Melanoma Surveillance Clinic Tel Aviv Medical Center, Israel
Education
- Tel Aviv University, Israel MD-PhD Track, Sackler Faculty of Medicine
Training
- Dermatology residency
- Research fellowship in immunogenetics and the skin microbiome
Publications
Book a Consultation
Clinic services are provided privately and via agreements with HMOs and insurers. The TAMC team is available for any request and committed to top-level care.
Frequently Asked Questions
What is basal cell carcinoma?
I see basal cell carcinoma very often. Many patients come in thinking it’s just a small spot that doesn’t heal. Sometimes it’s a shiny bump, sometimes a small pink area — it doesn’t always look alarming at first.
In most cases, basal cell carcinoma grows slowly. It usually doesn’t spread to other organs, but over time it can damage nearby tissue if we ignore it. That’s why early evaluation matters.
Treatment is usually straightforward, especially when we detect it early. The exact approach depends on the size, location, and a few other clinical factors.
This is general information and not a treatment recommendation. Every case should be evaluated individually.
What is squamous cell carcinoma?
Squamous cell carcinoma is a bit different. It can behave more aggressively than basal cell carcinoma, especially if diagnosis is delayed.
Patients often describe a rough patch, a lesion that keeps coming back, or a spot that starts bleeding. Sometimes it’s tender. Sometimes not. It can vary quite a bit.
The good news is that when we detect it early, treatment is usually very effective. The treatment plan depends on the size, location, and whether the tumor has spread.
This is general information and not a treatment recommendation. Every case should be evaluated individually.
What is melanoma?
Melanoma is the type of skin cancer that concerns patients the most — and understandably so. It can behave more aggressively than other skin cancers.
Often, patients notice changes in a mole. Sometimes a new lesion appears. Not every mole is dangerous, but if something looks different — it’s worth checking.
When melanoma is detected early, outcomes are usually very good. If diagnosed later, treatment becomes more complex and may involve systemic therapies.
This is general information and not a treatment recommendation. Every case should be evaluated individually.
What is cutaneous lymphoma?
Cutaneous lymphoma is relatively rare. Patients often come in thinking it’s eczema or another skin condition, because it can look similar.
Some types progress slowly and may not require immediate treatment. Others behave differently and need a more active approach. This really depends on the specific subtype.
Because of this variability, diagnosis and management usually require careful evaluation.
This is general information and not a treatment recommendation. Every case should be evaluated individually.
What is Merkel cell carcinoma?
Merkel cell carcinoma is rare, but it tends to grow quickly. Patients usually notice a small lump that increases in size over a short period of time.
Because this tumor can behave aggressively, early evaluation is important. Treatment decisions depend on several factors, including tumor size and stage.
This is general information and not a treatment recommendation. Every case should be evaluated individually.
Patient Reviews (0)
No reviews yet
